These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9808900)

  • 1. [Recommendations for the use of the hepatitis A vaccine in day care centers. Committee on Vaccines of the Spanish Pediatric Society and Spanish Association for the Study of the Liver].
    Gastroenterol Hepatol; 1998; 21(7):346-51. PubMed ID: 9808900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children.
    Richtmann R; Chaves RL; Mendonça JS; Konichi SR; Mitre HP; Takei K; Dietz K; Flehmig B
    J Med Virol; 1996 Feb; 48(2):147-50. PubMed ID: 8835347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against hepatitis A.
    Katz SL
    N Engl J Med; 1999 Jul; 341(4):293. PubMed ID: 10419395
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis A vaccine.
    Bancroft WH
    N Engl J Med; 1992 Aug; 327(7):488-90. PubMed ID: 1320741
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis A outbreak in a socially-contained religious community in rural southern Ontario.
    Hockin J; Isaacs S; Kittle D; Brimmer G; Bailey N; Tamblyn S
    Can Commun Dis Rep; 1997 Nov; 23(21):161-6. PubMed ID: 9397602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?].
    Leentvaar-Kuijpers A
    Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784
    [No Abstract]   [Full Text] [Related]  

  • 8. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-wide epidemic of hepatitis A--Shelby County, Tennessee.
    Skinner JT
    J Tenn Med Assoc; 1995 Dec; 88(12):468-9. PubMed ID: 8531480
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998.
    Deshaies D; Dion R; Valiquette L; Auger N
    Can Commun Dis Rep; 1998 Sep; 24(18):145-51. PubMed ID: 9780447
    [No Abstract]   [Full Text] [Related]  

  • 11. [Costs of hepatitis A prophylaxis in travelers].
    Zaaijer HL; Lelie PN
    Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of hepatitis A virus infection.
    Moyer L; Warwick M; Mahoney FJ
    Am Fam Physician; 1996 Jul; 54(1):107-14. PubMed ID: 8677827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(29):559-60. PubMed ID: 7616951
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis A vaccine: evidence of efficacy after exposure.
    Commun Dis Rep CDR Wkly; 1999 Apr; 9(16):139, 142. PubMed ID: 10341473
    [No Abstract]   [Full Text] [Related]  

  • 15. Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects.
    Ackerman Z; Ablin J; Shouval D
    Am J Gastroenterol; 1996 Feb; 91(2):413. PubMed ID: 8607537
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost-benefit analysis for hepatitis A vaccine].
    Chen E; Yao J; Yang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Aug; 20(4):224-7. PubMed ID: 10682501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial experience with an inactivated anti-hepatitis-A vaccine].
    Panà A; Franco E; Divizia M
    Nuovi Ann Ig Microbiol; 1988; 39(4-5):373-7. PubMed ID: 2855448
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroprevalence of hepatitis A in children--implications for hepatitis A vaccine.
    Mittal SK; Rastogi A; Rastogi A; Kumar N; Talukdar B; Kar P
    Trop Gastroenterol; 1998; 19(3):120-1. PubMed ID: 9828714
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis A in day-care centers. A community-wide assessment.
    Hadler SC; Webster HM; Erben JJ; Swanson JE; Maynard JE
    N Engl J Med; 1980 May; 302(22):1222-7. PubMed ID: 6245363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.